Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.
about
Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologiesNormal values for cardiovascular magnetic resonance in adults and childrenTissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imagingMyocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mappingRobust free-breathing SASHA T1 mapping with high-contrast image registration.Quantification of myocardial stiffness using magnetic resonance elastography in right ventricular hypertrophy: initial feasibility in dogsAdvances in parametric mapping with CMR imagingImportant advances in technology and unique applications related to cardiac magnetic resonance imaging.Diagnosis and management of ischemic cardiomyopathy: Role of cardiovascular magnetic resonance imaging.Review of Journal of Cardiovascular Magnetic Resonance 2012.Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography.Review of Journal of Cardiovascular Magnetic Resonance 2013T1-mapping in the heart: accuracy and precisionLeakage and water exchange characterization of gadofosveset in the myocardium.Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.Fibrosis quantification in Hypertensive Heart Disease with LVH and Non-LVH: Findings from T1 mapping and Contrast-free Cardiac Diffusion-weighted imagingMOLLI and AIR T1 mapping pulse sequences yield different myocardial T1 and ECV measurements.Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE.Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.Gadofosveset-based biomarker of tissue albumin concentration: Technical validation in vitro and feasibility in vivo.Single bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla.Myocardial T1 mapping: techniques and potential applications.Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging.Increased myocardial extracellular volume in active idiopathic systemic capillary leak syndromeQuantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlationGadolinium free cardiovascular magnetic resonance with 2-point Cine balanced steady state free precession.Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance.64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET: pharmacokinetic study in a rat model of chronic MIIncreased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophySystolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillationMyocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage.4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision.Influence of Off-resonance in myocardial T1-mapping using SSFP based MOLLI methodT1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophyCharacterization of Benign Myocarditis Using Quantitative Delayed-Enhancement Imaging Based on Molli T1 MappingAutomated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial Infarction.Standardization of T1 measurements with MOLLI in differentiation between health and disease--the ConSept study.Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.
P2860
Q26824231-91EFD0DF-B5F4-424B-BE45-C31EE4FFCAEBQ26998833-474D80A5-3B90-41BB-A7CF-3013A9E9248BQ27003231-759A89E0-DB52-4F93-A5B5-60347ADAE5CCQ27025677-483F7F75-15EC-4042-BEFC-61229D693D19Q27303536-5363A7F7-8D1E-40C6-B6E1-E2E30BD38D37Q30394955-750F7C5D-D40A-4FF6-B8B6-211B25AB00AEQ30412201-63D9F1DC-16EE-4920-9496-CFDB6AB4EE88Q30421137-D7ACF1AC-47A0-4A1C-B6AE-D3F800EDBAF1Q30424619-F7FD00D4-4779-4D57-B97C-E00D08C5067CQ30446298-EEF87F93-4F81-4836-9F20-BD672BB9DC67Q30456092-891915A2-7A05-4881-9CE1-DE6B646856A3Q30487473-426EF770-5467-4E41-A4C8-E9CB1366A163Q30725831-59D0BBAA-79D5-4157-8809-22463885E418Q30732433-782376A8-C22C-4450-9F78-AED2B8E5D7E3Q30867239-86B8F8AC-6C87-472A-860F-4E6A07A0FABFQ33673965-598F94B1-D6C1-4A85-9AB1-A060F1D03753Q34481677-01474B77-D8C6-4FE8-9E87-51E7AFFD476FQ34681124-13035216-EB51-40BF-A002-20529B06426DQ34817378-7B3490E9-CE6C-4C24-82FB-E7F88BFA9690Q34974971-2FF78A33-E040-4F28-9309-535726920A4DQ35030258-F3C8862A-9527-4C4A-8FA9-69C2EC48BC54Q35174325-EAE86348-1E3B-4373-A449-B36F5048E225Q35629034-CC28E606-6680-4B06-8BB1-56BED0C6BD19Q36000241-D64AF52A-5997-46F9-9BEB-96DA0CF45282Q36113656-CDDE431E-1473-4BA2-BE58-98D78A508BECQ36235217-4DA7A527-B3AC-4E0F-A2FF-B54FF8993935Q36344169-2E714BAB-1461-442E-8A95-9E025B4A037BQ36399845-28DFF0FF-1542-4D77-88F2-B2813ED5CD88Q36489696-68B9CABE-023D-48B9-B789-9C7DF2512326Q36691645-60422ACE-B3E2-4C18-AABE-39114D020FD2Q36836362-A6FBFB71-F59F-4F7B-A0CE-50D486D00FCFQ36851346-894FE8E6-B141-409D-9213-5EB19A4E22FAQ36944395-395C1098-B751-441F-A7B1-1C913CDD005CQ36985833-36F69D68-24D8-434C-8C12-4E72F53BD65CQ37070734-0519512D-7A5A-4EB2-9E85-FD61DF437B51Q37160724-D20754DA-7D29-411F-8357-7701923E26C8Q37176301-36F5650F-FFAF-4C8B-9C07-312FB72B75ACQ37240733-0BB72DCC-4C8E-47C5-98ED-95CA28526051Q37357328-1EF7D748-96E3-4157-8291-B6B8923DE20CQ37371632-F9DF41B5-2D8B-4A30-AACE-A13ADA9D0C65
P2860
Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Extracellular volume fraction ...... : initial clinical experience.
@ast
Extracellular volume fraction ...... : initial clinical experience.
@en
type
label
Extracellular volume fraction ...... : initial clinical experience.
@ast
Extracellular volume fraction ...... : initial clinical experience.
@en
prefLabel
Extracellular volume fraction ...... : initial clinical experience.
@ast
Extracellular volume fraction ...... : initial clinical experience.
@en
P2093
P2860
P50
P356
P1476
Extracellular volume fraction ...... : initial clinical experience.
@en
P2093
Joel R Wilson
Kirk M Druey
Sujata M Shanbhag
W Patricia Bandettini
P2860
P2888
P356
10.1186/1532-429X-14-64
P577
2012-09-11T00:00:00Z
P5875
P6179
1002584485